← All Lucid Diagnostics INC filings

Lucid Diagnostics INC 10-K annual reports

Annual reports — audited financials, the full risk-factor list, and management’s account of the year.

NASDAQ
LUCD
Lucid Diagnostics INC
10-K: Lucid Diagnostics: 2025 Growth, Funding, Going Concern
Lucid Diagnostics' 2025 annual report details revenue growth, significant capital raises, and key product advancements, alongside persistent operating losses and substantial doubt about its ability to continue as a going concern.
NASDAQ
LUCD
Lucid Diagnostics INC
10-K: Lucid Diagnostics' 10-K Filing Reveals Financial Strategies and Regulatory Hurdles
Lucid Diagnostics' 10-K filing details its financial position, including ongoing losses and efforts to secure Medicare coverage for its EsoGuard test amid evolving regulatory landscapes.
NASDAQ
LUCD
Lucid Diagnostics INC
10-K: Lucid Diagnostics Details Share Structure, Preferred Stock Offerings in 10-K Filing
Lucid Diagnostics' 10-K filing outlines its share structure, recent preferred stock offerings, and various agreements with PAVmed, its parent company.